Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants-Reply

JAMA. 2024 Jan 23;331(4):361-362. doi: 10.1001/jama.2023.24533.

Authors

Peter A Dargaville¹, John B Carlin², Peter G Davis³

Affiliations

¹ Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
² Clinical Epidemiology and Biostatistics Unit, Murdoch Children's Research Institute, Melbourne, Australia.
³ Neonatal Services, Royal Women's Hospital, Melbourne, Australia.

PMID: 38261047
DOI: 10.1001/jama.2023.24533

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Humans
Infant
Infant, Newborn
Infant, Premature*
Lipoproteins
Pulmonary Surfactants* / therapeutic use
Surface-Active Agents* / therapeutic use
Treatment Outcome

Substances

Lipoproteins
Pulmonary Surfactants
Surface-Active Agents